News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
News|Videos|August 7, 2015

Pancreatic Cancer: A Caregiver's Perspective

Advertisement
Your browser does not support the video tag.

Episodes in this series

EP. 1 What Pancreatic Cancer Is and The Risk Factors
EP. 1 What Pancreatic Cancer Is and The Risk Factors
EP. 2 A Cancer Patient's First-Hand Account of a Pancreatic Cancer Diagnosis
EP. 2 A Cancer Patient's First-Hand Account of a Pancreatic Cancer Diagnosis
EP. 3 Blood Tests, Biopsies, and Symptoms
EP. 3 Blood Tests, Biopsies, and Symptoms
EP. 4 Treatment Options for Pancreatic Cancer
EP. 4 Treatment Options for Pancreatic Cancer
EP. 5 Research for Pancreatic Cancer
EP. 5 Research for Pancreatic Cancer
EP. 6 Pancreatic Cancer: Staying Positive
EP. 6 Pancreatic Cancer: Staying Positive
EP. 7 Top Tips for Pancreatic Cancer Patients
EP. 7 Top Tips for Pancreatic Cancer Patients
EP. 8 Pancreatic Cancer: A Caregiver's Perspective
Now Playing
EP. 8 Pancreatic Cancer: A Caregiver's Perspective
EP. 9 Pancreatic Cancer: Coping With the Disease
EP. 9 Pancreatic Cancer: Coping With the Disease

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
The U.S. FDA has granted approval to Rybrevant Faspro, the first and only subcutaneous therapy for EGFR-mutated non-small cell lung cancer: © stock.adobe.com.

Rybrevant Faspro FDA-Approved as First Sub-Q Therapy for EGFR NSCLC

ByRyan Scott
December 18th 2025
Dave Coulier, best known for his role in the sitcom “Full House,” recently sat down with CURE to discuss facing cancer for the second time.

‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis

ByAlex Biese
December 17th 2025
The FDA has granted approval to treatment with Rubraca for some adult patients with previously-treated metastatic castration-resistant prostate cancer: © stock.adobe.com.

FDA Grants Regular Approval to Rubraca for Some With Prostate Cancer

ByAlex Biese
December 17th 2025
At CURE, we strive to provide insight, education and inspiration for patients, survivors and caregivers at every stage of the cancer journey: © stock.adobe.com.

Education and Inspiration Across the Cancer Journey

ByMike Hennessy Jr.
December 17th 2025
Brian Sluga

Testicular Cancer Survivor Shares Story of Courage in New Book

ByAlex Biese
December 17th 2025
Advertisement
Advertisement

Trending on CURE

1

‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis

2

Navigating the Holidays When Cancer Never Quite Leaves

3

FDA Grants Regular Approval to Rubraca for Some With Prostate Cancer

4

Rybrevant Faspro FDA-Approved as First Sub-Q Therapy for EGFR NSCLC

5

Padcev/Keytruda Combo Extends Survival in Muscle-Invasive Bladder Cancer

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.